Clinical importance of hypothyroxinemia in the preterm infant and a discussion of treatment concerns

Current Opinion in Pediatrics

Volumn 24, Issue 2, 2012, Pages

  La Gamma, Edmund F ^a,b   Paneth, Nigel ^c  

^a WESTCHESTER MEDICAL CENTER   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

cerebral palsy; extremely low birth weight; extremely low gestational age neonate; prematurity; transient hypothyroxinemia of prematurity; white matter injury

Indexed keywords

ADRENALIN; AMIODARONE; DOBUTAMINE; DOPAMINE; FUROSEMIDE; HEPARIN; IODIDE; OPIATE; PHENOBARBITAL; THYROTROPIN; THYROXINE; THYROXINE BINDING GLOBULIN; TRIACYLGLYCEROL;

ARTICLE; BEHAVIOR DISORDER; BRAIN DYSFUNCTION; CEREBRAL PALSY; COGNITIVE DEFECT; CONTINUOUS INFUSION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG SAFETY; ECONOMIC ASPECT; GESTATIONAL AGE; HEALTH CARE COST; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; HYPERTHYROIDISM; HYPOPITUITARISM; HYPOTHYROIDISM; HYPOTHYROXINEMIA; INTELLIGENCE QUOTIENT; LOW DRUG DOSE; MENTAL DEFICIENCY; NEONATAL WEIGHT LOSS; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL; TACHYCARDIA; THYROID FUNCTION; THYROID HORMONE METABOLISM; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME; TREMOR;

CEREBRAL PALSY; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; HORMONE REPLACEMENT THERAPY; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; THYROID HORMONES; THYROXINE;

EID: 84859042425     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32835067cc     Document Type: Article

References (134)

1. Lorenz JM, Wooliever DE, Jetton JR, Paneth N. A quantitative review of mortality and developmental disability in extremely premature newborns. Arch Pediatr Adolesc Med 1998; 152:425-435. (Pubitemid 28283012)
2. Vohr BR, Msall ME, Wilson D, et al. Spectrum of gross motor function in extremely low birth weight children with cerebral palsy at 18 months of age. Pediatrics 2005; 116:123-129.
3. Vohr BR, Stephens BE, Higgins RD, et al. All site follow-up PIs. The impact of Bayley III assessment: are outcomes of ELBW infants improving? PAS meeting, Vancouver, Canada, 2010.
4. Laptook AR, O'Shea TM, Shankaran S, the NICHD Network. Adverse neurodevelopmental outcomes among extremely low birth weight infants with a normal head ultrasound: prevalance and antecedents. Pediatrics 2005; 115:673-680.
5. Gargus RA, Vohr BR, Tyson JE, et al. Unimpaired outcomes for extremely low birth weight infants at 18 to 22 months. Pediatrics 2009; 124:112-121.
6. Kuban CK, Alfred EN, O'Shea TM, et al. Developmental correlates of head circumference at birth and two years in a cohort of extremely low gestational age newborns. J Pediatr 2009; 155:344-349.
7. Kuban KC, Leviton A. Cerebral palsy. N Engl J Med 1994; 330:188-195. (Pubitemid 24026889)
8. Vohr B, Stephens B, Higgins RD, Bann CM and Follow-up Principal Investigators of the Eunice Kennedy Shriver Neonatal Research Network. Are outcomes of extremely preterm infants really improving? Impact of Bayley assessment on outcomes. J Pediatr (in press).
9. Buehler JW, Kleinman JC, Hogue CJ, et al. Birth weight-specific infant mortality, United States, 1960 and 1980. Public Health Rep 1987; 102:151-161. (Pubitemid 17055769)
10. La Gamma EF. Transient hypothyroxinemia of prematurity: 10 reports from our group. Semin Perinatol 2008; 32:377-446.
11. Mercado M, Yu VY, Francis I, et al. Thyroid function in very preterm infants. Early Hum Dev 1988; 16:131-141.
12. La Gamma EF, van Wassenaer AG, Golombek SG, et al. Neonatal thyroxine supplementation for transient hypothyroxinemia of prematurity: beneficial or detrimental? Treat Endocrinol 2006; 5:335-346. (Pubitemid 44788151)
13. Fisher DA. Thyroid function in premature infants. The hypothyroxinemia of prematurity. Clin Perinatol 1998; 25:999-1014; viii.
14. Ogilvy-Stuart AL. Neonatal thyroid disorders. Arch Dis Child Fetal Neonatal Ed 2002; 87:F165-F171. (Pubitemid 35252928)
15. Rovet J. Congenital hypothyroidism: treatment and outcome. Curr Opin Endocrinol Diabetes Obes 2005; 12:42-52. (Pubitemid 40364518)
16. Kohler B, Schnabel D, Biebermann H, Gruters A. Transient congenital hypothyroidism and hyperthyrotropinemia: normal thyroid function and physical development at the ages of 6-14 years. J Clin Endocrinol Metab 1996; 81:1563-1567. (Pubitemid 26118593)
17. Tillotson SL, Fuggle PW, Smith I, et al. Relation between biochemical severity and intelligence in early treated congenital hypothyroidism: a threshold effect. BMJ 1994; 309:440-445. (Pubitemid 24252767)
18. Karna P. Developmental follow-up of very low birthweight premature infants with low free thyroxine. Am J Perinatol 1991; 8:288-291.
19. Reuss ML, Paneth N, Lorenz JM, et al. Correlates of low thyroxine values at newborn screening among infants born before 32 weeks gestation. Early Hum Dev 1997; 47:223-233. (Pubitemid 27087024)
20. Escobar GJ, Littenberg B, Petitti DB. Outcome among surviving very low birthweight infants: a meta-analysis. Arch Dis Child 1991; 66:204-211.
21. Qiu H, Paneth N, Lorenz JM, Collins M. Labor and delivery factors in brain damage, disabling cerebral palsy, and neonatal death in low-birth-weight infants. Am J Obstet Gynecol 2003; 189:1143-1149. (Pubitemid 37373911)
22. Paneth N. Does transient hypothyroxinemia cause abnormal neurodevelopment in premature infants? Clin Perinatol 1998; 25:627-643. (Pubitemid 28452915)
23. Reuss ML, Paneth N, Pinto-Martin JA, et al. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996; 334:821-827. (Pubitemid 26099604)
24. Golombek SG, La Gamma EF, Paneth N. Treatment of transient hypothyroxinemia of prematurity: a survey of neonatal practice. J Perinatol 2002; 22:563-565. (Pubitemid 35244039)
25. Glinoer D, Delange F. The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid 2000; 10:871-887.
26. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997; 18:404-433. (Pubitemid 27246883)
27. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol 2004; 151 (Suppl 3):U25-U37. (Pubitemid 39627053)
28. Calvo RM, Jauniaux E, Gulbis B, et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 2002; 87:1768-1777. (Pubitemid 34615267)
29. Contempre B, Jauniaux E, Calvo R, et al. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab 1993; 77:1719-1722. (Pubitemid 24000941)
30. Perlman JM. Neurobehavioral deficits in premature graduates of intensive care: potential medical and neonatal environmental risk factors. Pediatrics 2001; 108:1339-1348. (Pubitemid 33121477)
31. Lucas A, Morley R, Fewtrell MS, et al. Low plasma triiodothyronine concentrations and outcome in preterm infants. Arch Dis Child 1988; 63:1201-1206.
32. Hack M, Flannery DJ, Schluchter M, et al. Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med 2002; 346:149-157. (Pubitemid 34438880)
33. Zimmermann MB. Iodine deficiency. Endocr Rev 2009; 30:376-408.
34. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 2000; 85:3975-3987. (Pubitemid 32055337)
35. Simpson J, Williams FL, Delahunty C, et al. Serum thyroid hormones in preterm infants and relationships to indices of severity of intercurrent illness. J Clin Endocrinol Metab 2005; 90:1271-1279. (Pubitemid 40463976)
36. Williams FL, Ogston SA, van Toor H, et al. Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage. J Clin Endocrinol Metab 2005; 90:5954-5963. (Pubitemid 41606511)
37. Williams FL, Simpson J, Delahunty C, et al. Developmental trends incord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metab 2004; 89:5314-5320. (Pubitemid 39518403)
38. Botting N, Powls A, Cooke RW, Marlow N. Cognitive and educational outcome of very-low-birthweight children in early adolescence. Dev Med Child Neurol 1998; 40:652-660. (Pubitemid 28522130)
39. Jakobson LS, Frisk V, Knight RM, et al. The relationship between periventricular brain injury and deficits in visual processing among extremely-low-birthweight (<1000 g) children. J Pediatr Psychol 2001; 26:503-512. (Pubitemid 33131637)
40. Schmidt B, Asztalos EV, Roberts RS, et al. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA 2003; 289:1124-1129. (Pubitemid 37430326)
41. Kuban CK, Alfred EN, O'Shea TM, et al. An algorithm for identifying and classifying cerebral palsy in young children. J Pediatr 2008; 153:466-472.
42. Breslau N, Paneth NS, Lucia VC. The lingering academic deficits of low birth weight children. Pediatrics 2004; 114:1035-1040. (Pubitemid 41529770)
43. Zoeller RT, Rovet J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol 2004; 16:809-818. (Pubitemid 39489993)
44. Sharlin DS, Tighe D, Gilbert ME, Zoeller RT. The balance between oligodendrocyte and astrocyte production in major white matter tracts is linearly related to serum total thyroxine. Endocrinology 2008; 149:2527-2536. (Pubitemid 351574541)
45. Anderson GW, Schoonover CM, Jones SA. Control of thyroid hormone action in the developing rat brain. Thyroid 2003; 13:1039-1056. (Pubitemid 37464557)
46. Clarke BR, Conry RF, Dunn HG. Hearing impairment and associated factors. In: Dunn HG, editor. Sequelae of low birth weight: the Vancouver study. London: MacKeith Press; 1986.
47. Waber DP, McCormick MC. Late neuropsychological outcomes in preterm infants of normal IQ: selective vulnerability of the visual system. J Pediatr Psychol 1995; 20:721-735. (Pubitemid 26001818)
48. Vohr BR, Garcia-Coll C, Mayfield S, et al. Neurologic and developmental status related to the evolution of visual-motor abnormalities from birth to 2 years of age in preterm infants with intraventricular hemorrhage. J Pediatr 1989; 115:296-302. (Pubitemid 19190358)
49. Jongmans M, Mercuri E, Henderson S, et al. Visual function of prematurely born children with and without perceptual-motor difficulties. Early Hum Dev 1996; 45:73-82. (Pubitemid 26257929)
50. Bernal J, Guadano-Ferraz A, Morte B. Perspectives in the study of thyroid hormone action on brain development and function. Thyroid 2003; 13:1005-1012. (Pubitemid 37464553)
51. Cuevas E, Auso E, Telefont M, et al. Transient maternal hypothyroxinemia at onset of corticogenesis alters tangential migration of medial ganglionic eminence-derived neurons. Eur J Neurosci 2005; 22:541-551. (Pubitemid 41192265)
52. Leonard JL, Kaplan MM, Visser TJ, et al. Cerebral cortex responds rapidly to thyroid hormones. Science 1981; 214:571-573. (Pubitemid 12206157)
53. Leviton A, Paneth N, Reuss ML, et al. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr 1999; 134:706-711. (Pubitemid 30186813)
54. Ruiz-Marcos A, Cartagena-Abella P, Martinez-Galan JR, et al. Thyroxine treatment and the recovery of pyramidal cells of the cerebral cortex from changes induced by juvenile-onset hypothyroidism. J Neurobiol 1994; 25:808-818. (Pubitemid 24191249)
55. Luu TM, Ment L, Altan W, et al. Executive and memory function in adolescents born very preterm. Pediatrics 2011; 127:e639-e646.
56. Kuban KCK, O'Shea TM, Allred EN, et al. Prevalence and correlates of screening positive on the Modified Checklist for Autism in Toddlers (MCHAT) in extremely low gestational age newborns (ELGANs). J Pediatr 2009; 154:535-540.
57. Lucas A, Morley R, Fewtrell MS. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. BMJ 1996; 312:1132-1133; discussion 1133-1134.
58. Den Ouden AL, Kok JH, Verkerk PH, et al. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res 1996; 39:142-145. (Pubitemid 26003534)
59. Briet JM, van Wassenaer AG, Dekker FW, et al. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001; 107:712-718. (Pubitemid 32268456)
60. Briet JM, van Wassenaer AG, van Baar A, et al. Evaluation of the effect of thyroxine supplementation on behavioural outcome in very preterm infants. Dev Med Child Neurol 1999; 41:87-93. (Pubitemid 29074075)
61. Osborn DA. Thyroid hormone for preventing neurodevelopment impairment in preterm infants. Cochrane Database Syst Rev 2009. doi 10.1002/14651858.CD001070.
62. van Wassenaer AG, Briet JM, van Baar A, et al. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants. Pediatrics 2002; 110:534-539. (Pubitemid 34976682)
63. Ghassabian A, Bongers-Schokking JJ, Henrichs J, et al. Maternal thyroid function during pregnancy and behavioral problems in the of fspring: the generation R study. Pediatr Res 2011; 69:454-459. Reviews the importance of perinatal thyroid hormone levels on subsequent complex human behavior.
64. Kempers MJ, van Trotsenburg AS, van Tijn DA, et al. Disturbance of the fetal thyroid hormone state has long-term consequences for treatment of thyroidal and central congenital hypothyroidism. J Clin Endocrinol Metab 2005; 90:4094-4100. (Pubitemid 41058178)
65. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 2004; 18:225-248. (Pubitemid 38807301)
66. Vermiglio F, Lo Presti VP, Moleti M, et al. Attention deficit and hyperactivity disorders in the of fspring of mothers exposed to mild-moderate iodine deficiency: a possible novel iodine deficiency disorder in developed countries. J Clin Endocrinol Metab 2004; 89:6054-6060. (Pubitemid 39628414)
67. Van Wassenaer A, Westera J, Houtzager B, Kok J. Ten year follow-up of children born at <30 weeks gestational age supplemented with T4 in the neonatal period in a randomized, controlled trial. Pediatrics 2005; 116:e613-e618. (Pubitemid 46056391)
68. Henrichs J, Bongers-Schokking J, Schenk JJ, et al. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood; the generation R study. J Clin Endocrinol Metab 2010; 95:4227-4234. Illustrated the role of maternal thyroid hormone abnormalities in complex human behavior.
69. La Gamma EF, van Wassenaer AG, Ares S, et al. Phase 1trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks' gestation. Pediatrics 2009; 124:e258-e268.
70. van Wassenaer AG, Kok JH, de Vijlder JJ, et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 1997; 336:21-26. (Pubitemid 26428283)
71. Van Wassenaer A, Kok J. Trials with thyroid hormone in preterm infants: clinical and neurodevelopmental effects. Semin Perinatol 2008; 32:423-430.
72. Rapaport R, Rose SR, Freemark M. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr 2001; 139:182-188. (Pubitemid 32721702)
73. Fisher DA. Thyroid function and dysfunction in premature infants. Pediatr Endocrinol Rev 2007; 4:317-328. (Pubitemid 47104811)
74. Mitchell ML, Walraven C, Rojas DA, et al. Screening very-low-birthweight infants for congenital hypothyroidism. Lancet 1994; 343:60-61. (Pubitemid 24017632)
75. Kok JH, Briet JM, van Wassenaer AG. Postnatal thyroid hormone replacement in very preterm infants. Semin Perinatol 2001; 25:417-425. (Pubitemid 33140485)
76. Hume R, Richard K, Kaptein E, et al. Thyroid hormone metabolism and the developing human lung. Biol Neonate 2001; 80 (Suppl 1):18-21. (Pubitemid 32453711)
77. Rajatapiti P, Kester MH, de Krijger RR, et al. Expression of glucocorticoid, retinoid, and thyroid hormone receptors during human lung development. J Clin Endocrinol Metab 2005; 90:4309-4314. (Pubitemid 41058213)
78. Mackie AS, Booth KL, Newburger JW, et al. A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg 2005; 130:810-816. (Pubitemid 41265724)
79. Smit BJ, Kok JH, De Vries LS, et al. Motor nerve conduction velocity in very preterm infants. Muscle Nerve 1999; 22:372-377. (Pubitemid 29116191)
80. Bert J, Kok JH, de Vries LS, et al. Somatosensory evoked potentials in very preterm infants in relation to L-thyroxine supplementation. Pediatrics 1998; 101:865-869. (Pubitemid 28204838)
81. van Trotsenburg AS, Vulsma T, van Rozenburg-Marres SL, et al. The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab 2005; 90:3304-3311. (Pubitemid 41014290)
82. De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 1999; 84:151-164.
83. Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocr Rev 2005; 26:704-728. (Pubitemid 41127279)
84. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29:76-131. (Pubitemid 351252748)
85. Schonberger W, Grimm W, Emmrich P, et al. Reduction of mortality rate in premature infants by substitution of thyroid hormones. Eur J Pediatr 1981; 135:245-253. (Pubitemid 11137448)
86. Escobar-Morreale HF, del Rey FE, Obregon MJ, de Escobar GM. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology 1996; 137:2490-2502. (Pubitemid 26155786)
87. Alonso M, Goodwin C, Liao X, et al. Effects of maternal levels of thyroid hormone (TH) on the hypothalamus-pituitary-thyroid set point: studies in TH receptor beta knockout mice. Endocrinology 2007; 148:5305-5312. (Pubitemid 350012660)
88. Fisher DA. Development of fetal thyroid system control. In: Delong GR, Robbins J, Condliffe PG, editors. Iodine and the brain. New York: Plenum; 1989. pp. 167-176.
89. Fisher DA. Ontogenesis of hypothalamic-pituitary-thyroid function in the human fetus. In: Delange F, Fisher DA, Malvaux P, editors. Pediatric thyroidology. Basel: Karger; 1985. pp. 19-32.
90. Crisanti P, Omri B, Hughes E, et al. The expression of thyrotropin receptor in the brain. Endocrinology 2001; 142:812-822.
91. Zoeller RT, Crofton KM. Thyroid hormone action infetal brain development and potential for disruption by environmental chemicals. Neurotoxicology 2000; 21:935-945. (Pubitemid 32172145)
92. Adler SM, Wartofsky L. The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am 2007; 36:657-672; vi.
93. Connors JM, Hedge GA. Effect of continuous thyroxine administration on thyrotropin secretion in thyroidectomized rats. Endocrinology 1981; 108:2098-2102. (Pubitemid 11048150)
94. Connors JM, Hedge GA. Feedback effectiveness of periodic versus constant triiodothyronine replacement. Endocrinology 1980; 106:911-917. (Pubitemid 10135128)
95. Connors JM, Hedge GA. Feedback regulation of thyrotropin by thyroxine under physiological conditions. Am J Physiol 1981; 240:E308-E313. (Pubitemid 11137945)
96. Delange F, Dunn JT, Glinoer D. Recommendations on iodine nutrition for mothers and infants in Europe. Iodine deficiency disorders in Europe: a continuing concern. New York: Plenum Press; 1993. pp. 471-478.
97. Ares Segura S, Quero J, Jiminez S, et al. Iodine content of infant formulas and iodine intake of premature babies: high risk of iodine deficiency. Arch Dis Child 1994; 71:F184-F191.
98. Ares S, Quero J, Morreale de Escobar G. Neonatal iodine deficiency: clinical aspects. J Pediatr Endocrinol Metab 2005; 18 (Suppl 1):1257-1264. (Pubitemid 43019988)
99. Ares S, Escobar-Morreale HF, Quero J, et al. Neonatal hypothyroxinemia: effects of iodine intake and premature birth. J Clin Endocrinol Metab 1997; 82:1704-1712. (Pubitemid 127495172)
100. La Gamma EF, Gulati S, van Wassenaer AG, et al. Effects of Supplemental Thyroid Hormone on Heart Rate and Blood Pressure in Extremely Low Gestational Age Newborns (ELGANs) PAS meeting; Vancouver, Canada; 2010.
101. Soldin OP, Nandedkar AK, Japal KM, et al. Newborn thyroxine levels and childhood ADHD. Clin Biochem 2002; 35:131-136. (Pubitemid 34449701)
102. Chopra IJ. Clinical review 86: euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 1997; 82:329-334.
103. Gandy J, Wonko N, Kantoch MJ. Risks of intravenous amiodarone in neonates. Can J Cardiol 1998; 14:855-858.
104. Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the 'common' neurologic disorders? Neurology 2007; 68:326-337. (Pubitemid 46188246)
105. Huang W, Wood C, L'Abbe MR, et al. Soy protein isolate increases hepatic thyroid hormone receptor content and inhibits its binding to target genes in rats. J Nutr 2005; 135:1631-1635. (Pubitemid 40980710)
106. Conrad SC, Chiu H, Silverman N. Soy formula complicates management of congenital hypothyroidism. Arch Dis Child 2004; 89:37-40. (Pubitemid 38122005)
107. Soldin OP, Lai S, Lamm SH, et al. Lack of arelation between human neonatal thyroxine and pediatric neurobehavioral disorders. Thyroid 2003; 13:193-198. (Pubitemid 36596716)
108. Kempers MJ, Lanting CI, van Heijst AF, et al. Neonatal screening for congenital hypothyroidism based on thyroxine, thyrotropin, and thyroxinebinding globulin measurement: potentials and pitfalls. J Clin Endocrinol Metab 2006; 91:3370-3376. (Pubitemid 44402106)
109. Pass K. Overview of newborn screening for congenital hypothyroidism. In: Hauser P, Rovet J, editors. Thyroid diseases of infancy and childhood. Washington, DC: American Psychiatric Press; 1999. pp. 59-83.
110. Woo HC, Lizarda A, Tucker R, et al. Congenital hypothyroidism with adelayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes. J Pediatr 2011; 158:538-542. Recent characterization of the prevalence of late onset perinatal thyroid deficiency and its impact on long-term outcomes.
111. Hinton CF, Harris KB, Borgfeld L, et al. Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas. Pediatrics 2010; 125:S37-S47.
112. US Department of Health and Human Services. Newborn screening: toward a uniform screening panel and system. Rockville, MD: Maternal and Child Health Bureau; 2005.
113. Willi SM, Moshang T Jr. Diagnostic dilemmas. Results of screening tests for congenital hypothyroidism. Pediatr Clin North Am 1991; 38:555-566.
114. Yeung MY, Smyth JP. Hormonal factors in the morbidities associated with extreme prematurity and the potential benefits of hormonal supplement. Biol Neonate 2002; 81:1-15. (Pubitemid 34114108)
115. Valerio PG, van Wassenaer AG, de Vijlder JJ, Kok JH. A randomized, masked study of triiodothyronine plus thyroxine administration in preterm infants less than 28 weeks of gestational age: hormonal and clinical effects. Pediatr Res 2004; 55:248-253. (Pubitemid 38121003)
116. Jones I, Srinivas M, Ng L, et al. The thyroid hormone receptor beta gene: structure and functions in the brain and sensory systems. Thyroid 2003; 13:1057-1068. (Pubitemid 37464558)
117. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med 1995; 333:1688-1694. (Pubitemid 126634606)
118. Ibrahim K, Paneth N, LaGamma EF, Reed PL. Translation of clinical research trial findings into neonatal medical practice: a survey of practicing neonatologists. Poster Presentation at 'Late Breakers Symposium,' Pediatric Academic Societies (PAS), 2009.
119. Osborn DA, Hunt RW. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants (Review). Cochrane Reviews 2009. doi: 10.1002/14651858.CD005948.pub2.
120. Rouse DJ, Hirtz DG, Thom E, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359:895-905.
121. Fremantle N, Calvert M, Wood J, et al. Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA 2003; 289:2554-2559. (Pubitemid 37430157)
122. Axelstad M, Boberg J, Nellemann C, Kiersgaard M, et al. Exposure to the Widely Used Fungicide Mancozeb Causes Thyroid Hormone Disruption in Rat Dams but No Behavioral Effects in the of fspring. Toxicol sci 2011; 120:439-446.
123. Babu S, Sinha RA, Mohan V, Rao G, et al. Effect of hypothyroxinemia on thyroid hormone responsiveness and action during rat postnatal neocortical development. Exp Neurol 2011; 228:91-98.
124. Bourcigaux N, Lepoutre-Lussey C, Guechot J, Donadille B, et al. Thyroid function at the third trimester of pregnancy in a Northern French population. Ann Endocrinol 2010; 71:519-524.
125. Chan E, Burstyn I, Cherry N, Bamforth F, et al. Perfluorinated acids and hypothyroxinemia in pregnant women. Environ Res 2011; 111:559-564.
126. Costeira MJ, Oliveira P, Santos NC, Ares S, et al. Psychomotor Development of children from an Iodine-Deficient Region. J Pediatr 2011; 159:447-453.
127. Ghassabian A, Bongers-Schokking JJ, Henrichs J, et al. Maternal thyroid function during pregnancy and behavioral problems in the of fspring: the generation R study. Pediatr Res 2011; 69:454-459. [63]
128. Goissen C, Fontaine C, Braun K, Bony H, et al. Prospective study at 1week of life of thyroid function in 97 consecutive pre-term newborns under 32 weeks of gestation [French]. Arch Pediatr 2011; 18:253-260.
129. Henrichs J, Bongers-Schokking J, Schenk JJ, et al. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood; the generation R study. J Clin Endocrinol Metab 2010; 95:4227-4234. [68]
130. Murcia M, Rebagliato M, Iniguez C, Lopez-Espinosa MJ, et al. Effect of iodine Supplementation During Pregnancy on Infant Neurodevelopment at 1 Year of Age. Am J Epidemiol 2011; 173:804-812.
131. Negro R, Soldin OP, Obregon MJ, Stagnaro-Green A. HYPOTHYROXINEMIA AND PREGNANCY [Review]. Endocrine Practice 2011; 17:422-429.
132. Ramos HE, Morandini M, Carre A, Tron E, et al. Pregnancy in women heterozygous for MCT8 mutations: risk of maternal hypothyroxinemia and fetal care. Eur J Endocrinol 2011; 164:309-314.
133. Suzumura H, Nitta A, Tsuboi Y, Watabe Y, et al. Thyroxine for transient hypothyroxinemia and cerebral palsy in extremely preterm infants. Pediatr Int 2011; 53:463-467.
134. Woo HC, Lizarda A, Tucker R, et al. Congenital hypothyroidism with adelayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes. J Pediatr 2011; 158:538-542. [110]